Post-Market Clinical Follow-up (PMCF) template

What to consider when using a template for Post-Market Clinical Follow-up under the EU MDR

What is a Post-Market Clinical Follow-up (PMCF) template?

A Post-Market Clinical Follow-up (PMCF) template is a standardised template intended to serve as a “one size fits all” guide to developing a PMCF system and associated technical documents. Templates are often used by medical device manufacturers for support and guidance when developing a PMCF strategy, or when they feel that they do not have sufficient in-house expertise in developing PMCF systems.

A well-designed PMCF template should have sufficient flexibility to accommodate a wide-range of medical devices. It should empower the user to develop a basic PMCF structure that could then be documented in a PMCF plan before being enacted.

Can a PMCF template be used under the MDR?

Post-Market Clinical Follow-up requirements have changed following the introduction of the Medical Device Regulation (MDR). Under the out-going MDD, requirements for PMCF in many cases were comparatively light, meaning that a template-based PMCF system was often sufficient.

The Medical Device Regulation MDR 2017/745 fully replaces the MDD on 26th May 2021. It introduces a wide range of changes to the way medical devices are regulated, including a markedly increased level of prominence and scrutiny of PMCF systems. These changes mean that more care is needed when choosing a PMCF Template. Often, it may be beneficial for manufacturers to seek advice when working with PMCF templates.

Where can I find reliable templates for MDR Post-Market Clinical Follow-up?

Although many of the existing PMCF templates will fall short of MDR requirements, there are several sources of templates that can be useful when designing and implementing MDR Post-Market Clinical Follow-up systems.

The Medical Device Coordination Group produce a range of guidelines that, unlike the MedDev guidelines, have been updated to reflect changes introduced by the MDR. Guideline MDCG 2020-7 — Post-Market Clinical Follow-up (PMCF) Plan Template - A guide for manufacturers and notified bodies was published in April 2020 and outlines a detailed approach for writing a PMCF Plan. Working to the MDCG recommended structure will help ensure acceptability of the PMCF Plans format and contents when presented to a regulator.

The MDCG guideline still requires manufacturers to conceive of an overall Post-Market Clinical Follow-up design before the template can be effectively used. It is a detailed guide to writing a PMCF Plan; it is not intended to act as a guide to designing PMCF studies.

What other sources of help are available to achieve PMCF MDR compliance?

MDR Annex XIV Part B contains a useful set of information regarding objectives of PMCF systems and requirements for PMCF planning. It is recommended that manufacturers work through the Annex during planning or upgrading of PMCF systems.

Annex XIV Part B also contains useful information about the sections that must be included in a PMCF Plan. By using Annex XIV alongside MDCG 2020-7, manufacturers should be well-positioned to ensure MDR compliance of their Post-Market Clinical Follow-up system.

Further help can be obtained by contacting dedicated advisors and EU MDR consulting services who specialise in MDR PMCF.

Other considerations when using a template to meet PMCF requirements under the MDR

If you decide to work with a template to develop your Post-Market Clinical Follow-up system and documents, it is also important to consider the following general points:

  • Nature of adverse events. It is a requirement under Article 87 MDR that manufacturers collect data on serious incidents and adverse events. The possible range of adverse events differs markedly from one type of device to another, so the system intended to collect such data will need to be constructed around the nature and frequency of such incidences. An effective template must be designed with sufficient flexibility to adequately address this variability.
  • Clinical application. Having a basic, templated structure for a PMCF system is not the same thing as implementing a fully-functioning system. Clinical application of a PMCF system requires clinical knowledge — data must be produced, collected, appraised, interpreted and applied correctly in order to generate valid evidence that will pass regulatory scrutiny. While an effective template can lay the foundations of a fully-functioning system, it takes a wider team or specialist advice to bring this system to life.
  • Writing PMCF Plan and PMCF Evaluation Report. Annex XIV Part B of the MDR requires that a plan for a PMCF system is written in a technical document known as a PMCF Plan, and that results of PMCF are captured in a PMCF Evaluation Report. As with developing a PMCF system, correct drafting of these documents requires clinical acumen that goes beyond simple adherence to a standard template.

In summary, effectively implementing your MDR PMCF strategy through use of a PMCF template will require careful template selection against the above criteria. It will also require a careful focus on ensuring availability of the correct level of clinical expertise in order to bring the PMCF system to life and ensure maximum contribution to your regulatory strategy.

Need help with your MDR strategy?

Powerful PMCF systems for your MDR compliance

PMCF registries and plans for your medical devices designed by our MDR experts.

  • Study design & documents
  • PMCF plan development
  • Site on-boarding support
  • Real-time data collection

Find out more

Call us now to discuss your MDR requirements:

(+44) 0114 386 3349

Or send us your details and we will contact you:

MDR Consulting

Our team of MDR professionals are medical device regulatory consulting specialists offering tailored MDR compliance services.

MDR Training

Our comprehensive training services are delivered by experts and address all aspects of MDR compliance.

Who we work with

Our clients come from across the industry and range from pre-start businesses to stockmarket-listed multinationals. We also have key strategic partners based in the UK and Denmark.

  • It was a pleasure working with you. We are completely satisfied with your service and look forward to working with you again.

    CEO, EU medical software company
  • Your service surpassed our expectations and added value across our organisation. We now feel much better placed to prepare for the MDR.

    Chief Executive, MedTech pre-start
  • A comprehensive, detailed and highly professional service.

    Regulatory Manager, UK device manufacturer
  • International

    We work with medical device manufacturers based in the UK, Europe, the US and Asia, developing MDR strategies for both physical devices and software as a medical device.

  • Diversified

    Working with us gives you access to our growing international team of MDR-trained healthcare professionals from a wide variety of clinical backgrounds.

Read more about our team and philosophy

Get our free White Paper: Mastering the MDR — Our comprehensive summary of the EU MDR



We have compiled some of our frequently asked questions. If you'd like to know anything else about what we do, feel free to ask us a question.

  1. We can work with the majority of medical device manufacturers seeking compliance of their devices in accordance with Medical Device Regulation (EU) 2017/745, including both hardware and software devices. We also offer a free, no-obligation consultation, so please feel confident about discussing your requirements with a member of our team.

  2. No. We will work with you to produce systems and to support your EU MDR compliance, but we do not conduct research ourselves. We will provide tools for you to conduct your own Post-Market Surveillance. Our range of services are designed to assist you in this matter.

  3. Yes. We adhere to the highest standards of professionalism and regard maintaining confidentiality and data security as a cornerstone of our practice. We also comply fully with the requirements of GDPR.

  4. Our medical device regulatory consulting is built around a strict quality framework and we only work with clients who share this commitment to quality. Our CEO is a medical doctor with years of experience in the medical device industry and assumes personal responsibility for every project. Our product development process integrates client feedback throughout product production, ensuring a constant focus on your needs.

  5. We work with clients of all sizes and at all stages of their regulatory compliance journey. Our team are here to help and are happy to respond to general enquiries, even if you don't feel like you know where to start. We are experts at 'tuning in' to your requirements and will guide you through the entire process. Our free MDR Compliance Guide and suite of MDR downloads stand as proof of our commitment to help you understand your obligations under the MDR.

  6. Yes. Software as a Medical Device is an increasingly-important segment of the medical device market. We have extensive experience in building regulatory systems for medical software and offer a special application of all our MDR services for software products. We also offer unique downloads and white papers that focus specifically on Software as a Medical Device.

  7. At its core, working with the MDR is about working with clinical evidence. Whether you need to generate evidence for PMCF, analyse data for writing a CER, or build an MDR-ready PMS system, our medical experts have the clinical acumen to ensure that your clinical evidence is produced and interpreted with the highest levels of professionalism. Medical professionals work with clinical evidence all day. We bring their specialist capabilities directly to your MDR strategy.

  8. We believe in transparency and aim to build long-term relationships with our clients. This commitment is demonstrated by our customer-focused pricing strategy. You pay a small deposit upfront, only paying the balance when the work has been completed to your total satisfaction. For higher-value projects we offer flexible payment packages on an individual basis — please contact a member of our team to find out more.

  9. Yes. Our unique business model allows us to scale to accommodate almost any amount of work. Many of our medical professionals remain clinically active, meaning that we have trained more than we presently need. This system allows us to have ready availability of redundant capacity that can be called upon in the event of a surge in demand. Whatever your requirements, our unique business model allows us to step in faster than any of our competitors.

  10. Yes. We run a number of events throughout the year focusing on specific aspects of MDR compliance. We also offer a limited number of free webinars on a limited basis — subscribe to our newsletter to be notified early when we publish new events. Of course, we also have our extensive MDR Compliance Guide and free MDR downloads suite, both of which offer extensive training on all aspects of MDR compliance.

Do you have any questions about our MDR services?

Contact us